Omicron variant resembles other respiratory viruses, posing challenges for syndromic surveillance

HONOLULU — A reduced-dose regimen of the antifibrotic medication nintedanib (Ofev) held up in real-world clinical practice, an observational study found. Approved for the treatment

The FDA re­ject­ed Rock­et Phar­ma­ceu­ti­cals’ gene ther­a­py for leuko­cyte ad­he­sion de­fi­cien­cy-I (LAD-I), re­quest­ing “lim­it­ed ad­di­tion­al” man­u­fac­tur­ing in­for­ma­tion. The com­pa­ny an­nounced the … Sign up to